Skip to main content
. Author manuscript; available in PMC: 2016 Jul 6.
Published in final edited form as: Hemodial Int. 2016 Feb 3;20(3):392–398. doi: 10.1111/hdi.12407

Figure 2.

Figure 2

Boxplots of quarterly averages. Hemoglobin (top), EPO (middle), and IV iron (bottom) in quarter 1 (Q1=weeks 1–13), quarter 2 (Q2 = weeks 14–26), quarter 3 (Q3 = weeks 27–39), and quarter 4 (Q4 = weeks 40–52). Outliers are not shown. IV iron includes Venofer, Ferrlecit, and Infed. Number of patients in Q1, Q2, Q3, and Q4, were 9386, 7925, 6403, 4415, respectively.